NM_001363118.2:c.535G>A
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1
The NM_001363118.2(SLC52A2):c.535G>A(p.Gly179Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000973 in 1,612,838 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001363118.2 missense
Scores
Clinical Significance
Conservation
Publications
- Brown-Vialetto-van Laere syndrome 2Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Genomics England PanelApp, PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SLC52A2 | NM_001363118.2 | c.535G>A | p.Gly179Ser | missense_variant | Exon 3 of 5 | ENST00000643944.2 | NP_001350047.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000526 AC: 80AN: 152112Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.000104 AC: 26AN: 249722 AF XY: 0.0000739 show subpopulations
GnomAD4 exome AF: 0.0000527 AC: 77AN: 1460608Hom.: 0 Cov.: 31 AF XY: 0.0000454 AC XY: 33AN XY: 726602 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000526 AC: 80AN: 152230Hom.: 0 Cov.: 33 AF XY: 0.000497 AC XY: 37AN XY: 74418 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Brown-Vialetto-van Laere syndrome 2 Uncertain:1Benign:1
- -
- -
Inborn genetic diseases Uncertain:1
The p.G179S variant (also known as c.535G>A), located in coding exon 2 of the SLC52A2 gene, results from a G to A substitution at nucleotide position 535. The glycine at codon 179 is replaced by serine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at